Drug Technical Advisory Board has recommended a ban on the use of anti-obesity drug, 'Rimonabant', in the country for the possible side effects it can cause.The highest drug advisory body, in its meeting recently, has advised the Drug Controller General of India to take steps to ban Rimonabant and send instructions to the state licensing authorities to ask the manufacture to stop its production and take steps for issuing notification by the health ministry to formally ban the drug in the country, it is learnt.
The details can be read here.
No comments:
Post a Comment